Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,377,578
-$4,840,822 QoQ
Shares Held
142,755
0.0% QoQ
Ownership
0.320%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BRAIDWELL LP holds $238,238,242 across 8 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NEO |
Neogenomics Inc
|
4,918,202 | $71,756,567 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
89,395 | $44,819,077 | |
| 3 | CDNA |
CareDx, Inc.
|
1,220,602 | $34,787,157 | |
| 4 | DHR |
Danaher Corp /De/
|
150,627 | $28,691,430 | |
| 5 | GH |
Guardant Health, Inc.
|
147,850 | $22,181,935 | |
| 6 | NTRA |
Natera, Inc.
|
79,500 | $21,580,275 | |
| 7 | DGX |
Quest Diagnostics Inc
|
43,200 | $9,156,240 | |
| 8 | WAT |
Waters Corp /De/
|
14,040 | $5,265,561 |
All Filings in GRAL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,377,578 | 142,755 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,218,400 | 142,755 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||